Statements

2020

COT statements and position papers published in 2020. Please note that links to the national archive may not be compatible with accessibility readers.

Last updated: 12 February 2021

Position paper on CBD in food products (2020)

COT position paper on the potential risk of cannabidiol (CBD) in CBD food products

Statement on E(N)NDS - e-cigarettes (2020)

COT statement on the potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes)

Lay summary of COT statement on the potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes)

Framework for risk assessment of flavouring compounds in E(N)NDS – e-cigarettes

COT framework for risk assessment of flavouring compounds in electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes)

Addendum to the overarching statement on contaminants in the diet of children (2020)

Addendum to the COT overarching Statement on the potential risks from contaminants in the diet of infants aged 0 to 12 months and children aged 1 to 5 years

Lay summary addendum to the COT overarching Statement on the potential risks from contaminants in the diet of infants aged 0 to 12 months and children aged 1 to 5 years

Statement on interactions between xenobiotics and the human microbiota (2020)

COT statement on interactions between xenobiotics and the human microbiota and their potential toxicological implications

Lay summary of the COT statement on interactions between xenobiotics and the human microbiota and their potential toxicological implications